BioNTech confident vaccine can beat new mutation

BioNTech said Tuesday (December 22) that the COVID-19 vaccine developed with Pfizer should continue to be effective against the newly discovered variant of the virus circulating in the UK.
Managing director Ugur Sahin said the company is testing whether the vaccine will work to protect against the mutation and is expecting results in the next two weeks.
“It has nine mutations, not just a single mutation, and we don't know right now whether our vaccine can protect against this new variant. Scientifically speaking, however, it is very likely that the immune response of this vaccine can also deal with the new virus variant. "
Scroll to continue with the content
display
Microsoft and Redis
Meet the fast and fully managed in-memory data store.
Don't miss the opportunity to hear the unique perspectives from Microsoft and partner specialists and learn more about Azure Cache for Redis.
LEARN MORE
Sahin confirmed that further vaccination results for asymptomatic transmission are on the way.
"We expect to be able to update and provide information by the end of January or February that the vaccine can prevent asymptomatic infection."
BioNTech is preparing to send 12.5 million doses to EU countries by the end of the year, following approval by Brussels on Monday (December 21).
This week, countries around the world closed their borders with the UK, creating travel chaos and increasing the prospect of food shortages.
The World Health Organization also warned of a major alert of the variant, saying it was a normal part of developing a pandemic.
Video transcript
NARRATOR: BioNTech said Tuesday that the COVID-19 vaccine developed with Pfizer should continue to be effective against the newly discovered variant of the virus circulating in the UK. Managing director Ugur Sahin said the company is testing whether the vaccine will work to protect against the mutation and is expecting results in the next two weeks.
UGUR SAHIN: It has nine mutations, not just a single mutation. And we don't currently know whether our vaccine can also protect against this new variant. Scientifically, however, it is very likely that the immune response of this vaccine can also deal with the new virus variant.
NARRATOR: Sahine confirmed that further vaccination results for asymptomatic transmission are on the way.
UGUR SAHIN: We expect to be able to update and provide information by the end of January or February that the vaccine can prevent asymptomatic infection.
NARRATOR: BioNTech is preparing to send 12.5 million doses to EU countries on Monday by the end of the year, following approval by Brussels. This week, countries around the world closed their borders with the UK, creating travel chaos and increasing the prospect of food shortages. The World Health Organization also warned of major alum from the variant, saying it was a normal part of developing a pandemic.

You should check here to buy the best price guaranteed products.

Last News

Mike 'The Situation' Sorrentino Says 'Blondes Have More Fun' as He Debuts a New Look

Mike 'The Situation' Sorrentino Says 'Blondes Have More Fun' as He Debuts a New Look

A Few Drops of This Anti-Aging Face Oil Makes Me Feel Alive — and It Lessens Wrinkles With Each Use

Maxwell was 'lady' of Epstein's mansion, often teeming with young women, former worker says

a Goal from Florida Panthers vs. St. Louis Blues

Simone Biles Is Glowing While Showing Off Her Fit Legs And Butt In A New Bikini